Actively Recruiting
PsoBest - The German Psoriasis Registry
Led by Universitätsklinikum Hamburg-Eppendorf · Updated on 2025-01-27
3500
Participants Needed
1
Research Sites
1300 weeks
Total Duration
On this page
Sponsors
U
Universitätsklinikum Hamburg-Eppendorf
Lead Sponsor
B
Berufsverband der Deutschen Dermatologen e.V. (www.bvdd.de)
Collaborating Sponsor
AI-Summary
What this Trial Is About
Treatment of moderate to severe Psoriasis (Pso) and Psoriasis-Arthritis (PsA) is largely confined to systemic therapy in Germany. Systemic therapy includes conventional systemic therapy (e.g. fumaric acids, methotrexate, ciclosporin A) and biological treatment (e.g. adalimumab, etanercept). While short- and middle-term efficacy of most systemic treatments has been shown in clinical studies (and is incorporated in international guidelines), knowledge about long-term outcomes, optimal treatment and effectiveness under real-world conditions is still missing. PsoBest, the German registry on the treatment of moderate to severe Pso and PsA started in 2008 and documents the long-term course of patients being administered any biologic or conventional systemic antipsoriatic drug authorized in Germany for the first time. The registry evaluates the long-term course of 3,500 patients with Pso and PsA treated with systemic antipsoriatics.
CONDITIONS
Official Title
PsoBest - The German Psoriasis Registry
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with a diagnosis of plaque-type psoriasis or psoriatic arthritis confirmed by a dermatologist
- Age 18 years or older
- Starting a specific systemic drug for psoriasis treatment for the first time
- Provided informed consent to participate
- Have sufficient German language skills
You will not qualify if you...
- Lack of informed consent
- Currently participating in a clinical trial at the time of registry enrollment (data from patients who join a clinical trial during follow-up will be recorded but analyzed separately)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Nationwide group of dermatological centers, hospitals and medical offices
Hamburg, Germany
Actively Recruiting
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
25
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here